BP Chairman Removed Amid Allegations of Bullying and Overbearing Conduct Traders Express Skepticism Over Irans Timeline for Strait of Hormuz Reopening Wes Streeting Pledges Wealth Tax That Works with Capital Gains Tax Overhaul Meta Eyes Cloud Computing Business as Data Center Expansion Creates Excess Capacity Pentagon UFO Files Renew Public Interest in Alien Theories What It Means for Defense and Aerospace Sectors CBSE Portal Glitches and Security Concerns Trigger Government Probe Edtech Sector Under Scrutiny EFOI Q4 2024 Earnings Narrowed Loss Highlights Ongoing Restructuring Efforts SOWG Q3 2025 Earnings Significant EPS Miss Overshadows Quarter STUB Q1 2026 Earnings Earnings Per Share Surges Past Estimates Revenue Not Reported CCIF Q1 2026 Earnings Net Investment Income Misses Estimates Despite Small Stock Gain WEBTOON Entertainment Inc WBTN Q1 2026 Earnings EPS Beat on Cost Discipline Revenue Visibility Remains Limited Toast Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher BlackRock TCP Capital Corp TCPC Climbs 176 as Price Approaches Key Resistance Vornado Realty Trust VNO Shows Momentum With 225 Gain Approaching Resistance Level Corcept Therapeutics CORT Holds Near Support Amid Modest Gains Resistance at 6287 in Focus Cal Redwood Acquisition Corp CRAQ Holds Steady at 1026 Amid Minimal Price Movement Universe Pharmaceuticals Inc UPC Surges 9 as Momentum Builds Near Key Resistance BW Q1 2026 Earnings WiderthanExpected Loss as Stock Jumps 7 A Mixed Signal for Investors Central Pacific Financial Corp Q1 2026 Earnings Earnings Beat Driven by Solid Core Operations Shares Slip Slightly UK Inflation Drops to 28 but Analysts Warn of Potential Rebound Anthropic Microsoft in Talks for Custom AI Chip Deal Following 5 Billion Investment Graphic Packaging Holding Company GPK Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiencies Drive Profitability US Consumer Prices Rise 38 Annually in April Exceeding Expectations and Marking Highest Since May 2023 ATKR Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution CytomX Therapeutics CTMX Holds Steady at 376 as Consolidation Continues